title: Fatal gastric bleeding during sorafenib treatment for hepatocellular carcinoma recurrence after liver transplantation.
authors.forename: Andrea
authors.initials: A
authors.lastname: Mancuso
authors.forename: Aldo
authors.initials: A
authors.lastname: Airoldi
authors.forename: Raffaella
authors.initials: R
authors.lastname: Vigano
authors.forename: Giovambattista
authors.initials: G
authors.lastname: Pinzello
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects; D001557:Benzenesulfonates / Q000009:adverse effects*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000601:surgery; D017809:Fatal Outcome; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000601:surgery; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D011725:Pyridines / Q000009:adverse effects*; D000077157:Sorafenib; D013272:Stomach Diseases / Q000139:chemically induced*
chemical_list: D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib